HOHiroyuki Okimura

Hiroyuki Okimura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hiroyuki Okimura has a total of 60 co-authors. Here are the top co-authors by number of shared publications:

  • Yosuke Tarumi

    Department of Obstetrics and Gynecology Kyoto Prefectural University of Medicine, Graduate School of Medical Science Kyoto Japan

    5 shared publications
  • Fumitake Ito

    Department of Obstetrics and Gynecology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , Kyoto

    4 shared publications
  • Jo Kitawaki

    Department of Obstetrics and Gynecology Kyoto Prefectural University of Medicine, Graduate School of Medical Science Kyoto Japan

    4 shared publications
  • Yukiko Tanaka

    Department of Obstetrics and Gynecology Kyoto Prefectural University of Medicine, Graduate School of Medical Science Kyoto Japan

    4 shared publications
  • Eiko Maeda

    Department of Obstetrics and Gynecology Kyoto Prefectural University of Medicine, Graduate School of Medical Science Kyoto Japan

    3 shared publications
  • Taisuke Mori

    Obstetrics and Gynecology, Kyoto Prefectural University of Medicine, Kyoto, JPN

    3 shared publications

Latest Publications

  • Open Access

    PGRMC1 suppression enhances progesterone responsiveness in stromal cells of ovarian endometrioma

    by Yuko Izumi, Yosuke Tarumi, Kota Aoki, Ayaka Okamura, Akihisa Katayama, Koki Shimura, Hiroyuki Okimura, Hisashi Kataoka, Fumitake Ito, Izumi Kusuki, et al.

    In brief: Progesterone resistance in endometriosis reduces the efficacy of progestin therapy. This study demonstrates that progesterone receptor membrane component 1 (PGRMC1) inhibition enhances progesterone responsiveness in endometriotic cells and may improve the efficacy of progestin-based therapies for endometriosis. Progesterone resistance in endometriosis reduces the efficacy of progestin. The nonclassical progesterone receptor, progesterone receptor membrane component 1 (PGRMC1), may regulate progesterone signaling in the normal endometrium, but its expression and role in endometriosis remain unknown. We aimed to investigate PGRMC1 expression in endometriosis and its role in progesterone resistance. PGRMC1 expression in normal endometrium (NE), eutopic endometrium in patients with endometriosis (EE), and ovarian endometrioma (OE) was examined using immunohistochemistry. Cultured OE stromal cells (SCs) were subjected to PGRMC1 knockdown using small interfering RNA (siRNA) and treated with AG205 (a PGRMC1 inhibitor) and RU486 (a progesterone receptor [PR] inhibitor) under progesterone stimulation. Progesterone responsiveness was assessed by measuring insulin-like growth factor binding protein 1 (IGFBP1) and prolactin (PRL) expression through real-time PCR and enzyme-linked immunosorbent assay. PGRMC1 expression in NESCs and EESCs was significantly lower in the secretory phase than in the proliferative phase (p < 0.01), with no similar changes observed in OE. Following siRNA-mediated PGRMC1 knockdown in OESCs, IGFBP1 and PRL expression was significantly upregulated (p < 0.05). Notably, treatment with siRNA and progestin induced significantly higher IGFBP1 and PRL expression than treatment with progestin alone (p < 0.05). AG205 induced similar effects on IGFBP1and PRL expression (p < 0.05), suggesting that suppression of PGRMC1 expression enhances progestin responsiveness in OESCs. However, AG205-induced IGFBP1 expression was abolished following treatment with RU486, suggesting that PGRMC1 acts through PR. In conclusion, suppressing PGRMC1, which is consistently expressed throughout the menstrual cycle in endometriotic lesions, may restore progesterone sensitivity and improve the efficacy of progestin-based therapies for endometriosis.

  • Open Access

    Trends, Demographic Characteristics and Seasonal Patterns of Rectal Prolapse Surgery in Japan: A Nationwide Claims‐Based Analysis From 2014 to 2023

    by Masamitsu Kido, Tomohiro Arita, Hiroki Shimizu, Jun Kiuchi, Kenji Nanishi, Katsutoshi Shoda, Hiroyuki Okimura, Atsuko Fujihara, Kengo Yoshii, Atsushi Shiozaki

    Aim: This study investigated nationwide trends, demographic characteristics, and seasonal patterns of rectal prolapse surgery in Japan, using healthcare claims databases. Methods: Surgical data were extracted from the National Database of Health Insurance Claims (NDB) from 2014 to 2023. Procedures were classified by surgical approach as conventional or laparoscopic. Crude and age‐adjusted rates per 100 000 person‐years were calculated. Temporal trends were assessed using linear and Poisson regression. Seasonal variations (April 2019–March 2024) were evaluated using one‐way analysis of variance with post hoc comparisons, and correlations with meteorological variables were examined using Pearson's correlation coefficients. Results: Over the decade, a total of 62 407 overall surgeries were performed, with an average annual rate of 4.7 per 100 000 person‐years and an overall female‐to‐male ratio of 6.9:1. Overall surgery rates peaked at ages 85–89 in males (5.5 per 100 000 person‐years) and females (59.1). While age‐adjusted overall and conventional surgeries declined significantly, laparoscopic surgeries significantly increased (all p < 0.01). Age‐adjusted overall surgery rates declined significantly in both sexes (RR = 0.960 for males, 0.983 for females, and 0.979 overall; each p < 0.0001), particularly among younger women aged 30–39 years ( p < 0.0024). The mean seasonal overall surgeries exhibited distinct seasonal variation: 578.0 (SD 99.2) in spring, 440.0 (SD 85.9) in summer, 432.4 (SD 50.8) in autumn, and 544.4 (SD 71.8) in winter, and showed moderate negative correlations with temperature. Conclusion: This study provides contemporary epidemiological insights into surgical management of rectal prolapse in Japan.


  • Open Access

    Functional Impairment of Activated Regulatory T Cells as a Central Immunological Defect in Endometriosis

    by Yukiko Tanaka, Eiko Maeda, Hiroyuki Okimura, Maya Fujii, Yosuke Tarumi, Masahide Hamaguchi, Fukui Michiaki, Khaleque N. Khan, Jo Kitawaki, Taisuke Mori

    Background: Endometriosis is increasingly recognized as a disorder of impaired reproductive immune tolerance rather than solely an endocrine disease. Although previous studies have reported inconsistent findings regarding the number of regulatory T cells (Tregs), the functional integrity of distinct Treg subsets and their contribution to disease pathogenesis remains unclear. Methods: We reviewed clinical, experimental, and translational studies focusing on regulatory T‐cell biology in endometriosis, with emphasis on functional Treg subsets, immune interactions within ectopic lesions, and emerging immunomodulatory therapeutic approaches. Main Findings: Accumulating evidence indicates that endometriosis is characterized not by a reduction in total Foxp3 + Treg numbers but by a qualitative deficiency of activated regulatory T cells (aTregs). Local loss of aTregs in ectopic endometrium and ovarian endometrioma is associated with enhanced inflammatory and angiogenic activation, including increased IL‐6, CCL2, and VEGF production, macrophage activation, and dysregulated Th17 responses. Experimental studies using Treg‐depleted mouse models further demonstrate that impaired Treg‐mediated regulation accelerates lesion growth, whereas adoptive Treg transfer suppresses inflammation and disease progression. Conclusion: Functional impairment of activated regulatory T cells represents a central immunological defect underlying chronic inflammation, lesion persistence, and infertility in endometriosis. Restoration of Treg‐mediated immune regulation may provide a promising nonhormonal, fertility‐preserving therapeutic strategy.

  • Open Access

    Human Chorionic Gonadotropin Injection to Retrieve Mature Oocytes During Laparoscopic Surgery for Ovarian Tissue Cryopreservation: A Case Report

    by Hiroyuki Okimura, Akika Iwata, Mari Kawamata, Yuko Izumi, Hisashi Kataoka, Fumitake Ito, Taisuke Mori, Daisuke Mori

    For young women with cancer facing the risk of infertility due to upcoming chemotherapy or radiotherapy, embryo cryopreservation (ECP), oocyte cryopreservation (OCP), and ovarian tissue cryopreservation (OTC) have been proposed. For some adolescent and adult patients who need immediate initiation of cancer treatment as well as prepubertal patients, only OTC is an option for fertility preservation. However, OCP is recommended for patients who can choose both OCP and OTC because the live birth rate after OTC is still insufficient. In this case, we were able to perform OCP as well as OTC with human chorionic gonadotropin (hCG) injection before surgery for a pubertal girl. The parents of a 15-year-old girl undergoing radiotherapy and chemotherapy (vincristine) after brain surgery for medulloblastoma approached our department to request fertility preservation for their daughter. Her menstruation had stopped, and maintenance chemotherapy (cisplatin, vincristine, cyclophosphamide) was scheduled one month after the current treatment ended. We informed them about the utility of each fertility preservation method and recommended OTC for the patient during her break from chemotherapy. The parents desired OCP because the pregnancy rate for OTC and ovarian tissue transplantation (OTT) was not satisfactory. With magnetic resonance imaging (MRI) showing small follicles and the resumption of menstruation in the patient, we decided to conduct follicle aspiration for OCP during surgery for OTC. Thirty-five hours before laparoscopic oophorectomy for OTC, hCG was injected. During laparoscopic surgery, all three small follicles that were visible were manually aspirated with an 18-gauge needle. Two oocytes, one mature and one degenerated, were retrieved. The mature oocyte and unilateral ovarian tissue were cryopreserved. The patient was discharged two days after OTC and returned four days later for maintenance chemotherapy. For young patients with cancer undergoing OTC, hCG administration may be an effective therapeutic option for retrieving mature oocytes during surgery.


  • Adoptive transfer of regulatory T cells inhibits the progression of endometriosis-like lesions in regulatory T-cell-depleted mice

    by Eiko Maeda, Hiroyuki Okimura, Yukiko Tanaka, Maya Fujii, Yosuke Tarumi, Hisashi Kataoka, Akemi Koshiba, Masahide Hamaguchi, Michiaki Fukui, Taisuke Mori, et al.

    STUDY QUESTION: Does the restoration of regulatory T cells (Tregs) suppress the progression of endometriosis? SUMMARY ANSWER: Adoptive transfer of Tregs suppresses the progression of endometriosis and reduces the levels of helper T (Th)-cell-related and proinflammatory cytokines in mice. WHAT IS KNOWN ALREADY: Endometriosis is a chronic inflammatory gynecological disease, which involves multiple immune components. Activated Treg counts decrease in the endometrioma and endometrium of patients with endometriosis, and depletion of Tregs exacerbates endometriosis in mice. STUDY DESIGN, SIZE, DURATION: We evaluated the effects of adoptive transfer of Tregs on the progression of endometriosis in mice. We used Foxp3tm3Ayr/J (Foxp3DTR) mice with temporarily ablated Tregs by injecting diphtheria toxin to develop an endometriosis model, which was generated by ovariectomy, estradiol administration and transplantation of uterine fragments from donor mice. Foxp3DTR mice were randomly divided into Treg adoptive transfer (n = 12) and control (n = 11) groups. Tregs were isolated from lymph nodes and spleens of wild-type (WT) mice and were adoptively transferred into mice that were temporarily Treg-depleted. Control mice were injected with vehicle. Treg adoptive transfer was performed on the day of uterine implantation, and a second adoptive transfer was performed after 14 days. Mice were euthanized 28 days after uterine implantation, and blood, peritoneal fluid, spleen, and endometriosis-like lesion samples were collected. PARTICIPANTS/MATERIALS, SETTING, METHODS: Foxp3DTR mice were intravenously injected with Tregs isolated from WT mice. The number, total weight, and total volume of the endometriosis-like lesions were evaluated on Day 28 following implantation of uterine fragments. The proportion of Tregs in endometriosis-like lesions, ascites, and peripheral blood was analyzed by flow cytometry. Inflammation in lesions and serum was examined using real-time PCR and ELISA. MAIN RESULTS AND THE ROLE OF CHANCE: Injection of Tregs increased their total count and decreased the number (P < 0.0001), weight (P = 0.0021), and volume (P = 0.0010) of endometriosis-like lesions in Foxp3DTR Treg-depleted mice. Furthermore, injection of Tregs decreased the mRNA expression of Th 1-, 2-, and 17-related cytokines, including interferon gamma (P = 0.0101), interleukin (IL)-4 (P = 0.0051), and IL-17 (P = 0.0177), as well as the levels of the proinflammatory cytokine IL-6 (P = 0.0002), in endometriosis-like lesions of Foxp3DTR Treg-depleted mice. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: Treg-related immune mechanisms in mice may not precisely reflect those in humans. WIDER IMPLICATIONS OF THE FINDINGS: Restoration of Tregs may be a useful therapeutic strategy for inhibiting the progression of endometriosis in cases where the decrease in the Treg population is an exacerbating factor. STUDY FUNDING/COMPETING INTEREST(S): This study was partially supported by the Grants-in-Aid for Scientific Research (grant numbers 18K16808 and 20K22983) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The sponsor had no role in the study design, collection, analysis and interpretation of data, writing of the report, and decision to submit the article for publication. The authors have no conflicts of interest to disclose.


  • Open Access

    A case of ovarian carcinosarcoma with germline BRCA2 pathogenic variant

    by Kaori Yoriki, Yuko Izumi, Yosuke Tarumi, Hiroyuki Okimura, Eiko Maeda, Taisuke Mori

    Ovarian carcinosarcoma in hereditary breast and ovarian cancer syndrome is rare. A 43‐year‐old woman with a family history of prostate and uterine or ovarian cancer had an 8‐cm mass in the right ovary. Although computed tomography suggested peritoneal dissemination to the Douglas pouch, she wanted to preserve her fertility; therefore, she underwent a right salpingo‐oophorectomy. Histopathological diagnosis was carcinosarcoma consisting of high‐grade serous carcinoma and sarcomatous components, including cartilage. Three weeks later, she underwent radical surgery. The disease was classified as advanced stage IIIB (FIGO 2014). A germline BRCA2 pathogenic variant was identified. After postoperative adjuvant chemotherapy, maintenance therapy with a poly(adenosine diphosphate‐ribose) polymerase (PARP) inhibitor was continued for 25 months without recurrence. A detailed examination of a mass in her left breast at her first visit revealed a ductal carcinoma in situ. PARP inhibitors may be effective as maintenance therapy for advanced ovarian carcinosarcoma with germline BRCA mutations.


  • Changes in the proportion of regulatory T cell subpopulations during menstrual cycle and early pregnancy

    by Hiroyuki Okimura, Yukiko Tanaka, Maya Fujii, Koki Shimura, Eiko Maeda, Fumitake Ito, Khaleque N. Khan, Yoshitaka Nakamura, Taisuke Mori, Jo Kitawaki

    Problem: Regulatory T cells (Tregs) play important roles in diseases occurring in women of reproductive age and pregnancy. Tregs are functionally heterogeneous and can be divided into activated Tregs (aTregs), resting Tregs (rTregs), and non‐suppressive Tregs (non‐Tregs). The purpose of this study is to investigate the change of Treg subpopulations during the menstrual cycle and early pregnancy.Method of study: Two groups of women were enrolled: healthy women aged 20 to 39 years with normal menstrual cycles and patients scheduled to undergo frozen‐thawed blastocyst transfer (FT‐BT) (subfertile women). Peripheral blood samples were collected at day 5 of the onset of menstruation (follicular phase), 0–2 days after luteinizing hormone (LH) surge (periovulatory phase), and 7–11 days after LH surge (luteal phase) from 20 healthy women. From 23 subfertile women, samples were collected at day 5 (the day of BT) and day 14 (the day of pregnancy testing) of progestogen administration during FT‐BT cycle and 9 weeks of gestation if the patient got pregnant. The proportion of total Treg and its subpopulations among CD4+ T cells was analyzed.Results: TTreg and aTreg proportion expanded during periovulatory phase (p < .01) and after pregnancy (p < .05 for tTreg and p < .01 for aTreg). rTreg proportion was significantly high during periovulatory phase (p < .01) and during luteal phase (p < .01). Non‐Tregs showed no significant change.Conclusions: RTregs and aTregs, especially in luteal phase and after getting pregnant, showed significant changes and may play important roles in women of reproductive age.


  • Identifying Issues in Fertility Preservation for Childhood and Adolescent Patients with Cancer at Pediatric Oncology Hospitals in Japan

    by Tadashi Maezawa, Nao Suzuki, Hiroki Takeuchi, Chikako Kiyotani, Keishiro Amano, Dai Keino, Hiroyuki Okimura, Mitsuru Miyachi, Maki Goto, Seido Takae, et al.

    Purpose: We conducted a questionnaire survey in 15 pediatric oncology hospitals in Japan to better understand the current status of fertility preservation in childhood and adolescents. Methods: The survey period was from September 2020 to December 2020. We mailed questionnaires to 64 departments involved in pediatric cancer treatments at the 15 hospitals. The primary outcomes were the timing of providing explanations on fertility preservation, presence of health care provider while providing explanations, cooperation between medical staff, and cooperation between hospitals. Results: The response rate was 100% (64/64). Regarding the time at which this information was provided, 79.6% of patients (43/54) received it before cancer treatment; 5.6% (3/54), after remission; and 14.8% (8/54), both time points. Nurses were mostly in attendance (70%) when oncologists provided information to patients. Nine (60%) hospitals did not have a reproductive department. Among these, 28.6% of the respondents referred patients to a reproductive facility that performed fertility preservation. Providing information about fertility preservation was challenging owing to the shortage of specific explanatory materials (35.1%) and the lack of cooperation between pediatric oncologists and reproductive endocrinologists (24.6%). Conclusion: Based on this survey, educational activities regarding fertility preservation centered on pediatric oncologists and nurses are needed. Furthermore, a system for providing explanatory materials for fertility preservation and encouraging cooperation at the physician and hospital levels is also needed (IRB No. H2020-111).


  • Open Access

    Equilin in conjugated equine estrogen increases monocyte-endothelial adhesion via NF-κB signaling

    by Fumitake Ito, Taisuke Mori, Yosuke Tarumi, Hiroyuki Okimura, Hisashi Kataoka, Yukiko Tanaka, Akemi Koshiba, Jo Kitawaki

    The adhesion of monocytes to endothelial cells, which is mediated by adhesion molecules, plays a crucial role in the onset of atherosclerosis. Conjugated equine estrogen, which is widely used for estrogen-replacement therapy, contains both estrone sulfate and various nonhuman estrogens, including equilin. To investigate the association between various estrogen types and atherosclerosis risk, we examined their effect on adhesion-molecule expression in human umbilical vein endothelial cells (HUVECs). In estrogen-treated HUVECs, the mRNA and protein expression levels of adhesion molecules were quantified by real-time polymerase chain reaction and enzyme immunoassay. Additionally, a flow-chamber system was used to assess the effects of estrogens on the adherence of U937 monocytoid cells to HUVECs. Equilin, but not 17β-estradiol (E2) or other types of estrogen, significantly increased the mRNA (P < 0.01) and protein (P < 0.05) expression of the adhesion molecules E-selectin and intercellular adhesion molecule-1 as compared with levels in controls. Equilin treatment increased the adherence of U937 monocytoid cells to HUVECs relative to the that in the control (P < 0.05), decreased estrogen receptor (ER)β expression, and increased the expression of proteins involved in nuclear factor kappa-B (NF-κB) activation relative to levels in controls. Furthermore, the accumulation of NF-κB subunit p65 in HUVEC nuclei was promoted by equilin treatment. By contrast, E2 treatment neither increased the number of adhered monocytoid cells to HUVECs nor altered the expression of ERβ or NF-κB-activating proteins. Our findings suggest that in terms of the adhesion of monocytes at the onset of atherosclerosis, E2 may be preferable for estrogen-replacement therapy. Further studies comparing equilin treatment with that of E2 are needed to investigate their differential impacts on atherosclerosis.


  • Endometrioid carcinoma arising from diaphragmatic endometriosis treated with laparoscopy: A case report

    by Hiroyuki Okimura, Hiroshi Tatsumi, Fumitake Ito, Suguru Yamashita, Tetsuya Kokabu, Jo Kitawaki

    Malignant transformation of diaphragmatic endometriosis is rare. We present a case of endometrioid carcinoma arising from diaphragmatic endometriosis treated with laparoscopy. A 59‐year‐old primigravida woman who had undergone abdominal hysterectomy for adenomyosis at the age of 47 years was referred to our hospital for investigation of a tumor on the surface of the liver. An integrated positron emission tomography‐computed tomography scan revealed a 3‐cm nodule on the surface of the liver with abnormal fluorine‐18‐deoxyglucose accumulation. Partial resection of the diaphragm and liver was performed. Histopathological examination revealed an endometrioid carcinoma arising from diaphragmatic endometriosis. We additionally performed laparoscopic bilateral salpingo‐oophorectomy and partial omentectomy. The resected tissues revealed no malignancy. Adjuvant chemotherapy with paclitaxel and carboplatin was administered. In cases of diaphragmatic tumors, endometriosis and its associated malignancies should be considered. Laparoscopic surgery is effective in patients with such conditions.